Pyridoxine 5′-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pyridoxine 5′-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 12, Pages -
Publisher
Springer Nature
Online
2017-12-14
DOI
10.1038/s41419-017-0050-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miRWalk2.0: a comprehensive atlas of microRNA-target interactions
- (2015) Harsh Dweep et al. NATURE METHODS
- Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome
- (2014) P. B. Mills et al. BRAIN
- Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway
- (2014) XINGXING WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Pyridox(am)ine-5-Phosphate Oxidase Deficiency Treatable Cause of Neonatal Epileptic Encephalopathy With Burst Suppression
- (2014) Andrea Guerin et al. JOURNAL OF CHILD NEUROLOGY
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- TGF- Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment
- (2013) T.-L. Yeung et al. CANCER RESEARCH
- A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer
- (2013) Dong-Joo Cheon et al. CLINICAL CANCER RESEARCH
- Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses
- (2013) L Galluzzi et al. ONCOGENE
- The Intestine Plays a Substantial Role in Human Vitamin B6 Metabolism: A Caco-2 Cell Model
- (2013) Monique Albersen et al. PLoS One
- Clinical significance of serum transforming growth factor-beta 1 (TGF-β1) levels in patients with epithelial ovarian cancer
- (2013) Faruk Tas et al. TUMOR BIOLOGY
- Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
- (2012) Jie Li et al. Journal of Hematology & Oncology
- Recent progress in the diagnosis and treatment of ovarian cancer
- (2011) Danijela Jelovac et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Vitamin B6 salvage enzymes: Mechanism, structure and regulation
- (2010) Martino Luigi di Salvo et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy
- (2010) Jian-Liang Chou et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- MicroRNAs and Their Therapeutic Potential for Human Diseases: MicroRNAs, miR-143 and -145, Function as Anti-oncomirs and the Application of Chemically Modified miR-143 as an Anti-cancer Drug
- (2010) Yukio Kitade et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Molecular Basis of Reduced Pyridoxine 5′-Phosphate Oxidase Catalytic Activity in Neonatal Epileptic Encephalopathy Disorder
- (2009) Faik N. Musayev et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PNPO deficiency: An under diagnosed inborn error of pyridoxine metabolism
- (2008) Morad Khayat et al. MOLECULAR GENETICS AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search